CJC-1295 / Ipamorelin — 5/5mg

Overview

CJC-1295 and Ipamorelin are two peptides often studied together in experimental research related to growth hormone signaling and endocrine system regulation.

CJC-1295 is a synthetic analog of growth hormone releasing hormone (GHRH), while Ipamorelin is a peptide that interacts with receptors involved in growth hormone release. When studied together, researchers investigate how these peptides influence growth hormone signaling pathways within the hypothalamic-pituitary axis.

Because growth hormone signaling plays an important role in metabolism, tissue repair, and endocrine system coordination, peptides that influence these pathways are frequently used as research tools to study hormonal regulation.

Quick Facts

Peptides	CJC-1295 and Ipamorelin
Peptide Class	Growth hormone signaling peptides
Research Focus	Endocrine system regulation
Biological System	Hypothalamic-pituitary axis

Mechanism of Action (Research Understanding)

Growth Hormone Releasing Hormone Signaling

CJC-1295 mimics the activity of naturally occurring growth hormone releasing hormone produced in the hypothalamus.

Ghrelin Receptor Signaling

Ipamorelin interacts with receptors associated with ghrelin signaling, which may influence growth hormone secretion.

Endocrine Coordination

Researchers study how these two peptides interact to influence growth hormone signaling networks.

[Study reference: Journal of Endocrinology]

Areas of Scientific Research

• endocrine physiology • growth hormone signaling pathways • metabolic hormone regulation • hypothalamic-pituitary axis communication